Join to View Full Profile
12605 E 16th AveUniv CO Hosp-NeuroScience CtrAurora, CO 80045
Phone+1 720-848-2080
Fax+1 720-848-0640
Dr. Corboy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Corboy is a neurologist located in Aurora, CO, with subspecialties in neuroimmunology and multiple sclerosis. He completed his medical education at the Perelman School of Medicine at the University of Pennsylvania, followed by an internship and residency in internal medicine and neurology at the University of Pennsylvania Health System. Dr. Corboy has expertise in general neurology, neuroimmunology, and neuroimaging. He has authored > 100 publications in journals such as Science, Lancet Neurology, Nature Neuroscience and JAMA Neurology, focusing on multiple sclerosis and related neuroimmunological conditions. His involvement in clinical trials includes studies on risk factors in early multiple sclerosis and the effects of various treatments, including the first randomized controlled trial of discontinuation of disease modifying therapies in MS. Dr. Corboy has been recognized as a Regional Top Doctor and has received a CMS Meaningful Use Stage 1 Certification. He is in a Phased retirement as of October, 2024.
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1986 - 1989- University of Pennsylvania Health SystemInternship, Internal Medicine, 1985 - 1986
Perelman School of Medicine at the University of PennsylvaniaClass of 1985
Certifications & Licensure
CO State Medical License 1994 - 2027
MN State Medical License 1992 - 1994
PA State Medical License 1987 - 1994
MD State Medical License 1989 - 1992
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition Start of enrollment: 2011 Oct 01
- Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial) Start of enrollment: 2012 Oct 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.John R Corboy, Robert J Fox, Gary Cutter, Eric Engebretson, Aaron Miller
Multiple Sclerosis. 2025-02-01 - 3 citationsA cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states.John F Tuddenham, Mariko Taga, Verena Haage, Victoria S Marshe, Tina Roostaei
Nature Neuroscience. 2024-12-01 - 1 citationsEscalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.Andrew B Wolf, John R Corboy
Neurology. Clinical Practice. 2024-10-01
Journal Articles
- Adjustments in Torque Steadiness During Fatiguing Contractions Are Inversely Correlated with IQ in Persons with Multiple SclerosisJohn Corboy, MD, Frontiers in Neurology
Press Mentions
Deciding Whether Multiple Sclerosis Treatment Should Be DiscontinuedMarch 24th, 2025- Stopping DMTs in Older MS Patients: What the Data ShowMarch 3rd, 2025
- Risks of Ending Disease-Modifying Therapy May Be ‘Minimal’ in Older, Stable Adults with MSFebruary 28th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
